Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ostrosky, Luis Zeichner
NCT05894577: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)	Completed	3	1453	US	Placebo, Montelukast	Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center	Covid19	07/23	01/24
NCT04885530: ACTIV-6: COVID-19 Study of Repurposed Medications	Completed	3	10956	US	Ivermectin, Ivermectin Tablets, Fluvoxamine, Fluvoxamine Maleate Tablets, Fluticasone, Fluticasone Furoate, Placebo, Montelukast, Metformin	Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center	Covid19	04/24	04/24
NCT06042855: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)	Completed	3	3214	US	Placebo, Metformin	Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center	Covid19	06/24	11/24
SCYNERGIA, NCT03672292 / 2018-002565-18: Evaluate Safety and Efficacy of the Coadministration of Ibrexafungerp With Voriconazole in Patients With Invasive Pulmonary Aspergillosis	Terminated	2	22	Europe, Canada, US, RoW	SCY-078, Ibrexafungerp, Voriconazole, Oral Placebo Tablets, SCY-078 matching Placebo	Scynexis, Inc., SCYNEXIS, Inc.	Invasive Pulmonary Aspergillosis	03/23	03/23
RECOVER-VITAL, NCT05595369: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms	Active, not recruiting	2	964	US	Experimental: Paxlovid 25 day dosing, Experimental: Paxlovid 15 day dosing, Placebo Comparator: Control	Kanecia Obie Zimmerman	Long COVID, Long Covid19	08/24	03/25
NCT06404047: RECOVER-ENERGIZE Platform Protocol	Recruiting	N/A	660	US	Personalized Cardiopulmonary Rehabilitation, Structured Pacing, Education, Usual Care	Duke University, National Heart, Lung, and Blood Institute (NHLBI)	Long COVID, Long Covid19, Long Covid-19	10/25	01/26